×
About 215,234 results

ALLMedicine™ Hepatitis Center

Research & Reviews  101,581 results

Hepatitis C during disease modifying therapy with Fingolimod for Relapsing Remitting Mu...
https://doi.org/10.1136/bcr-2020-238167
BMJ Case Reports; Aslanyan A, Anwar-Hashim Z et. al.

Feb 27th, 2021 - We present a case of 48-year-old woman with relapsing remitting multiple sclerosis (MS), who switched disease modifying therapy from Copaxone to Fingolimod due to her clinical and radiological MS disease progression. Unexpectedly after 2.5 years o...

Hepatitis C viraemic and seroprevalence and risk factors for positivity in Northwest Ca...
https://doi.org/10.1186/s12879-021-05826-0 10.1186/s13027-016-0071-z 10.1111/hepr.12367 10.1371/journal.pone.0088552 10.1371/journal.pone.0183530 10.1214/16-STS605 10.1214/aos/1176346391 10.1016/S0140-6736(18)32750-8 10.1371/journal.pone.0177022
BMC Infectious Diseases; Lynch E, Falq G et. al.

Feb 27th, 2021 - Despite a dramatic reduction in HCV drug costs and simplified models of care, many countries lack important information on prevalence and risk factors to structure effective HCV services. A cross-sectional, multi-stage cluster survey of HCV seropr...

Community screening identifies undiagnosed chronic liver disease in high-risk populations.
https://doi.org/10.1111/jgh.15473
Journal of Gastroenterology and Hepatology; Maher S, Dowdell L et. al.

Feb 27th, 2021 - Liver cirrhosis is the primary risk factor for the development of hepatocellular carcinoma (HCC). Most conditions that lead to cirrhosis are treatable, or modifiable. Therefore, a community-based screening program targeting high-risk groups was de...

Pathologic Predictive Factors for Late Recurrence of Hepatocellular Carcinoma in Chroni...
https://doi.org/10.1111/liv.14835
Liver International : Official Journal of the Internation... Nahm JH, Lee HS et. al.

Feb 27th, 2021 - Late recurrence of hepatocellular carcinoma (HCC) is regarded as de novo HCC from chronic hepatitis. This study investigated clinicopathological and molecular factors to develop a nomogram for predicting late HCC recurrence (> 2 years after curati...

Transient elastography in HIV infected patients with liver steatosis identifies a high ...
https://doi.org/10.2174/1570162X19666210225085002
Current HIV Research; Pezzini MF, Cheinquer H et. al.

Feb 26th, 2021 - To assess the role of TE in HIV infected patients with NAFLD. HIV infected patients undergoing ART were enrolled between August2016 and February2017. ≥18 years with undetectable HIV viral load. pregnancy; alcohol intake ≥20g/day and co-infection w...

see more →

Guidelines  337 results

EuroGuiDerm Guideline on the systemic treatment of Psoriasis vulgaris - Part 2: specifi...
https://doi.org/10.1111/jdv.16926
Journal of the European Academy of Dermatology and Venere... Nast A, Smith C et. al.

Feb 6th, 2021 - This evidence- and consensus-based guideline on the treatment of psoriasis vulgaris was developed following the EuroGuiDerm Guideline and Consensus Statement Development Manual. The second part of the guideline provides guidance for specific clini...

Fibrosis regression after eradication of hepatitis C virus - from bench to bedside.
https://doi.org/10.1053/j.gastro.2020.09.065
Gastroenterology Rockey DC, Friedman SL

Feb 2nd, 2021 - Hepatitis C virus (HCV) infection and its complications have been the major cause of cirrhosis and its complications for several decades in the Western world. Until recently, treatment for HCV with interferon-based regimens was associated with mod...

Adult Primary Liver Cancer Treatment (PDQ®)–Health Professional Version
https://www.cancer.gov/types/liver/hp/adult-liver-treatment-pdq?cid=eb_govdel
National Cancer Institute

Jan 14th, 2021 - HCC is relatively uncommon in the United States, although its incidence is rising, principally in relation to the spread of hepatitis C virus infection.[2] Worldwide, HCC is the sixth most prevalent cancer and the third leading cause of cancer-rel...

Chemical Risk Factors of Primary Liver Cancer: An Update
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7801911/
Hepatic Medicine: Evidence and Research; Barsouk A, Thandra KC et. al.

Jan 4th, 2021 - Primary liver cancer has the sixth highest incidence and fourth highest cancer mortality worldwide. Hepatitis B is the leading cause of liver cancer, though its incidence is decreasing with vaccination. Alcohol is the leading cause of liver transp...

Screening for Hepatitis B Virus Infection in Adolescents and Adults: US Preventive Serv...
https://doi.org/10.1001/jama.2020.22980
JAMA , Krist AH et. al.

Dec 15th, 2020 - An estimated 862 000 persons in the US are living with chronic infection with hepatitis B virus (HBV). Persons born in regions with a prevalence of HBV infection of 2% or greater, such as countries in Africa and Asia, the Pacific Islands, and part...

see more →

Drugs  359 results see all →

Clinicaltrials.gov  106,441 results

Hepatitis C during disease modifying therapy with Fingolimod for Relapsing Remitting Mu...
https://doi.org/10.1136/bcr-2020-238167
BMJ Case Reports; Aslanyan A, Anwar-Hashim Z et. al.

Feb 27th, 2021 - We present a case of 48-year-old woman with relapsing remitting multiple sclerosis (MS), who switched disease modifying therapy from Copaxone to Fingolimod due to her clinical and radiological MS disease progression. Unexpectedly after 2.5 years o...

Hepatitis C viraemic and seroprevalence and risk factors for positivity in Northwest Ca...
https://doi.org/10.1186/s12879-021-05826-0 10.1186/s13027-016-0071-z 10.1111/hepr.12367 10.1371/journal.pone.0088552 10.1371/journal.pone.0183530 10.1214/16-STS605 10.1214/aos/1176346391 10.1016/S0140-6736(18)32750-8 10.1371/journal.pone.0177022
BMC Infectious Diseases; Lynch E, Falq G et. al.

Feb 27th, 2021 - Despite a dramatic reduction in HCV drug costs and simplified models of care, many countries lack important information on prevalence and risk factors to structure effective HCV services. A cross-sectional, multi-stage cluster survey of HCV seropr...

Community screening identifies undiagnosed chronic liver disease in high-risk populations.
https://doi.org/10.1111/jgh.15473
Journal of Gastroenterology and Hepatology; Maher S, Dowdell L et. al.

Feb 27th, 2021 - Liver cirrhosis is the primary risk factor for the development of hepatocellular carcinoma (HCC). Most conditions that lead to cirrhosis are treatable, or modifiable. Therefore, a community-based screening program targeting high-risk groups was de...

Pathologic Predictive Factors for Late Recurrence of Hepatocellular Carcinoma in Chroni...
https://doi.org/10.1111/liv.14835
Liver International : Official Journal of the Internation... Nahm JH, Lee HS et. al.

Feb 27th, 2021 - Late recurrence of hepatocellular carcinoma (HCC) is regarded as de novo HCC from chronic hepatitis. This study investigated clinicopathological and molecular factors to develop a nomogram for predicting late HCC recurrence (> 2 years after curati...

Transient elastography in HIV infected patients with liver steatosis identifies a high ...
https://doi.org/10.2174/1570162X19666210225085002
Current HIV Research; Pezzini MF, Cheinquer H et. al.

Feb 26th, 2021 - To assess the role of TE in HIV infected patients with NAFLD. HIV infected patients undergoing ART were enrolled between August2016 and February2017. ≥18 years with undetectable HIV viral load. pregnancy; alcohol intake ≥20g/day and co-infection w...

see more →

News  6,335 results

'CAP' Quantification of Liver Fat Not Reliable for Routine Use
https://www.medscape.com/viewarticle/945499

Feb 8th, 2021 - NEW YORK (Reuters Health) - Ultrasound-based controlled attenuation parameter (CAP), a noninvasive tool for assessment of hepatic steatosis, should be used with caution because while results are reliable in patients with viral hepatitis, that's no...

Progress and Challenges in US Perinatal HBV Prevention Program
https://www.medscape.com/viewarticle/945121

Feb 2nd, 2021 - NEW YORK (Reuters Health) - The United States has made progress in identifying infants born to hepatitis B surface antigen (HBsAg)-positive women and getting them vaccinated. Yet, there is also substantial room for improvement, including closing t...

Incidence of Autoimmune Hepatitis May Be Rising
https://www.medscape.com/viewarticle/945131

Feb 1st, 2021 - The incidence of autoimmune hepatitis (AIH) may be rising, according to a prospective population-based study conducted in New Zealand. From 2008 to 2016, the rising incidence of AIH led to a 40% increase in point prevalence, reported lead author M...

US Supreme Court Rebuffs Merck Appeal in Hepatitis C Patent Fight With Gilead
https://www.medscape.com/viewarticle/944303

Jan 19th, 2021 - (Reuters) - The U.S. Supreme Court on Tuesday rejected Merck & Co Inc's bid to revive a $2.54 billion jury verdict it won against rival drugmaker Gilead Sciences Inc for infringing a patent in a dispute over a blockbuster hepatitis C treatment. Th...

Adult Primary Liver Cancer Treatment (PDQ®)–Health Professional Version
https://www.cancer.gov/types/liver/hp/adult-liver-treatment-pdq?cid=eb_govdel
National Cancer Institute

Jan 14th, 2021 - HCC is relatively uncommon in the United States, although its incidence is rising, principally in relation to the spread of hepatitis C virus infection.[2] Worldwide, HCC is the sixth most prevalent cancer and the third leading cause of cancer-rel...

see more →

Patient Education  181 results see all →